The close relationship between gastroparesis and diabetes makes this condition a significant public health concern.

CuraCell Holding’s CTA has received approval from Germany's Paul-Ehrlich-Institut (PEI) to begin a Phase I/IIa trial of CC-38 ...

Aligos has initiated dosing in the Phase II B-SUPREME trial of its ALG-000184 in people with chronic hepatitis B virus (HBV) ...